The results showed that inhibiting or conditionally knocking out MMP-13 significantly enhanced immune reinstatement and improved immunotherapy efficacy, emphasizing that tumor-induced comprehensive effects from OP-GMP crosstalk persist beyond tumor presence. Here, MMP13 is linked to neoplasm.